abstract |
The invention relates to aryl-substituted heterocyclyl sulfones of general formula (II) as blockers of voltage-dependent calcium channels, to pharmaceutical compositions containing such compounds, as well as to such compounds for use for the treatment and / or prevention of pain, stroke, mood disorders, epilepsy, schizophrenia and neurodegenerative disorders |